Federal funding for psychological research is in chaos. Here's one lab's story of the impacts of this funding confusion and ...

In a new study, researchers have found that a new chemical compound derived from the herbs could help to combat Alzheimer's disease and provide a new approach to treating the condition in the future ...

Q Genetics secured investment from K-Ground Partners' IP Fund, giving impetus to its new drug development endeavors. Subsequent to the completion of its Phase 1 trial, t ...

Scientists in California have developed a new chemical compound derived from rosemary and sage plants, which has already shown encouraging results in mice with Alzheimer's. The compound, carnosic acid ...

Compliance and precision are non-negotiable in highly regulated industries. Customer relationship management (CRM) ...

Dear Shareholders, As envisioned, 2025 is unfolding to be an exciting year for CytoDyn Inc. ("CytoDyn" or the "Company"). On February 24, 2025 ...

In one advertisement, Fife flagged in 2023, a skin substitute representative whose company name has been redacted boasts of a ...

Q4 2024 Earnings Conference Call March 18, 2025 4:30 PM ETCompany ParticipantsKurt Gustafson - Chief Financial OfficerMatt ...

Learn how drug absorption and predictive modeling drive advancements in pharmaceuticals and precision medicine.

RedHill plans to submit UK MAA1 for Talicia for H. pylori infection, using MHRA's2 new fast-track approval process, referencing FDA approval, with potential UK approval ...

Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for cutting-edge treatment. The CAR T-cell therapy involves the col ...

Neurodegenerative diseases represent a significant challenge in medical science, impacting millions globally. Despite advancements in diagnostic technology, ...